Target intelligence / Profile preview

Bacterial lectin

Molecular classification
Lectin, Carbohydrate-binding protein, Adhesin (in some contexts), Bacteriocin (specific bacterial lectins with antimicrobial action), Other
01

Overview

Bacterial lectins are carbohydrate-binding proteins produced by bacteria that specifically recognize and bind certain sugar structures, typically on host cell surfaces or in the extracellular environment[2]. Their primary biological function is to mediate the attachment or adherence of bacteria to host cells, which is generally a prerequisite for bacterial colonization and subsequent infection[3]. In addition to mediating host interactions, some specialized bacterial lectins, such as lectin-like bacteriotoxic proteins, act as bacteriocins—they selectively kill related bacterial species through mechanisms involving specific carbohydrate recognition domains[1]. Structurally, many bacterial lectins resemble plant lectins and may possess multiple carbohydrate-binding domains with specificity for sugars like mannose[1]. While bacterial lectins are considered therapeutic targets, especially in the context of blocking adhesion as an anti-infective strategy, there are challenges in developing drugs due to potential effects on commensal flora and host carbohydrate-binding proteins.

Other names
Microbial lectinBacterial carbohydrate-binding protein
02

Mechanism of action

Drugs or inhibitors (glycomimetics) block lectin-carbohydrate binding, thereby preventing bacterial adhesion or colonization or antagonizing bacteriotoxic effects

03

Biological functions

Mediating attachment of bacteria to host cellsPromoting bacterial colonizationRecognizing and binding carbohydrates on cell surfacesFacilitating infectionIn some cases: bactericidal activity against competing bacteria
04

Disease associations

InfectionInflammation (secondary to infection)Other (e.g., involvement in microbiome interactions, bacterial competition)
05

Safety considerations

Inhibiting bacterial lectins could alter normal microbiome or disrupt beneficial bacterial colonizationTargeting bacterial lectins could provoke off-target effects on host lectins or immune responsesPotential for immune reactions to anti-lectin therapeutics
06

Interacting drugs

None established as approved drugs; experimental inhibitors and antagonists exist in research settings (e.g., certain glycomimetics or mannose analogs, but no specific named drugs identified)
07

Biomarkers

Bacterial lectin gene or protein expression (for infection diagnostics or as research biomarkers)Null (no established clinical biomarkers for patient selection or efficacy monitoring with approved drugs)

Beyond the preview

Go deeper on Bacterial lectin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial lectin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call